HEB, Hemispherx Biopharma (AMEX)NEW Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mad2 who wrote (368)	9/25/1998 11:32:00 PM
From: Marty	of 857

Thanks for the reference. I read both articles. I suppose you could interpret the outcome of the lawsuit as you have, particularly if you like the short side, which it appears you do. I don't think anybody, even DuPont, gives up that much money without good reasons. Absent any other information about the suit, I'm inclined to accept the obvious, that Carter was right and DuPont was wrong. The other guy suing Carter also dropped his suit. The article also stated, for what it is worth, that "Neither Du Pont nor HEM has soured on future corporate partnerships." There could be all kinds of reasons Carter did not "redeem" the work on Ampligen and AIDS, including more promising results with CFS patients. Nothing wrong with that. Research can take you in all kinds of directions. I don't see anything sinister there and I don't attach any "stink" to him or HEB in all the things the short sellers have dredged up from 10 years ago. I may be prejudiced, but I've seen the kind of outright lies and half truths short sellers have done on other stocks in an attempt to drive them down. If anything stinks, it is that tactic.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next